Bory Pharmaceutical: intends to repurchase company shares with a value of 10-20 million yuan.

Baiorui Pharma announced that it plans to repurchase company shares with an amount ranging from 10 million to 20 million RMB, at a repurchase price not exceeding 139.77 RMB per share. The repurchased shares will be used for equity incentives or employee stock ownership plans. The estimated number of repurchased shares is 71,500 to 143,100, accounting for 0.02% to 0.03% of the total share capital of the company. The source of funds for the repurchase is the company's own funds, and the repurchase period is within 12 months from the date of approval by the Board of Directors.